Results 51 to 60 of about 993,013 (333)

Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease [PDF]

open access: yes, 2010
Copyright @ 2010 Cancer Research UK. This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.Background: α ...
J Anastassiou   +11 more
core   +1 more source

Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma

open access: yesBMC Gastroenterology, 2011
Background More than 50% of the worldwide cases of hepatocellular carcinoma occur in China, and this malignancy currently represents the country's second leading cause of cancer death in cities and the leading cause in rural areas.
Qiao You-Lin   +3 more
doaj   +1 more source

Early hepatocellular carcinoma developed within dysplastic nodule as nodule-within-nodule appearance: Case report with literature review

open access: yesRadiology Case Reports, 2022
Close follow-up of patients with liver cirrhosis has led to increased detection of hepatocellular carcinoma (HCC) at an early stage, especially with magnetic resonance imaging (MRI) innovations.
Farid Aassouani, MD   +11 more
doaj   +1 more source

Tumor-suppressing effects of autophagy on hepatocellular carcinoma

open access: yesLiver Research, 2018
Evasion of apoptosis is one of the hallmarks of hepatocellular carcinoma (HCC) that results in treatment resistance. Recently, autophagy was reported to induce cell death in HCC, highlighting the tumor-suppressing effects of autophagy on HCC. This review
Lijun Pang, Kai Liu
doaj   +1 more source

Hemorrhagic cerebral metastasis as a first manifestation of a hepatocellular carcinoma: case report [PDF]

open access: yesArquivos de Neuro-Psiquiatria, 1998
We report herein a rare instance in which a patient presented with a hemorrhagic cerebral metastasis as the initial manifestation of a hepatocellular carcinoma (HCC).
MARIO FERNANDO PRIETO PERES   +5 more
doaj   +1 more source

Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma [PDF]

open access: yes, 2011
Background: MicroRNA-21 (miR-21) is up-regulated in tumor tissue of patients with malignant diseases, including hepatocellular carcinoma (HCC). Elevated concentrations of miR-21 have also been found in sera or plasma from patients with malignancies ...
Polta, Andreas   +55 more
core   +2 more sources

The role of IL-4 gene polymorphism in HCV-related hepatocellular carcinoma in Egyptian patients

open access: yesEgyptian Liver Journal, 2021
Background Interleukin-4 (IL-4), a pleiotropic anti-inflammatory cytokine, is produced mainly by activated T helper 2 (Th2). Hepatocellular carcinoma (HCC) is a typical inflammation-related cancer.
Mohy-Eldin Abd-Elfattah   +4 more
doaj   +1 more source

Surgical oncology of hepatocellular carcinoma (HCC) [PDF]

open access: yesOrvosi Hetilap, 2010
A hepatocellularis carcinoma (HCC) gyakorisága világszerte növekszik. Hazánkban évente körülbelül 600 új esettel lehetne számolni, de a rendelkezésre álló adatok szerint ennél sokkal kevesebb jut a hepatológiai gondozás rendszerébe. A sorafenib megjelenése és az ablatív kezelések terjedése mellett a legjobb eredmények a sebészi módszerektől várhatók ...
openaire   +2 more sources

Epidermal growth factor polymorphism (rs4444903) predicts hepatocellular carcinoma in Egyptian population [PDF]

open access: yesResearch Journal of Applied Biotechnology, 2019
Hepatocellular carcinoma (HCC) is the most common primary hepatic malignancy in the world, with an increasing worldwide prevalence. Hepatocellular carcinoma (HCC) is the fifth most common cancer and thethird leading cause of cancer related mortality ...
Mohamed Elshal   +3 more
doaj   +1 more source

DNAAF5 promotes hepatocellular carcinoma malignant progression by recruiting USP39 to improve PFKL protein stability

open access: yesFrontiers in Oncology, 2022
PurposesDynein axonemal assembly factor 5 (DNAAF5) is the transcription factor of regulating the cytoskeleton and hydrodynamic protein complex assembly, however, it was not well elucidated in the malignant progression of hepatocellular carcinoma (HCC ...
Yaping Liu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy